Merck EPS - Earnings per Share 2012-2025 | MKKGY

Merck annual and quarterly earnings per share history from 2012 to 2025. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Merck EPS for the quarter ending September 30, 2025 was $0.48, a 18.34% increase year-over-year.
Merck EPS for the twelve months ending September 30, 2025 was $1.51, a 11.8% increase year-over-year.
Merck 2024 annual EPS was $1.38, a 1.57% decline from 2023.
Merck 2023 annual EPS was $1.41, a 12.84% decline from 2022.
Merck 2022 annual EPS was $1.61, a 3.07% decline from 2021.

Merck Annual EPS
2024	$1.38
2023	$1.41
2022	$1.61
2021	$1.66
2020	$1.04
2019	$0.68
2018	$1.83
2017	$1.35
2016	$0.83
2015	$0.57
2014	$0.60
2013	$0.74
2012	$0.34
2011	$0.37

Merck Quarterly EPS
2025-09-30	$0.48
2025-06-30	$0.34
2025-03-31	$0.36
2024-12-31	$0.33
2024-09-30	$0.41
2024-06-30	$0.30
2024-03-31	$0.35
2023-12-31	$0.29
2023-09-30	$0.37
2023-06-30	$0.35
2023-03-31	$0.39
2022-12-31	$0.31
2022-09-30	$0.43
2022-06-30	$0.42
2022-03-31	$0.45
2021-12-31	$0.42
2021-09-30	$0.41
2021-06-30	$0.41
2021-03-31	$0.42
2020-12-31	$0.23
2020-09-30	$0.43
2020-06-30	$0.15
2020-03-31	$0.23
2019-12-31	$0.17
2019-09-30	$0.18
2019-06-30	$0.24
2019-03-31	$0.10
2018-12-31	$1.32
2018-09-30	$0.18
2018-06-30	$0.14
2018-03-31	$0.19
2017-12-31	$0.54
2017-09-30	$0.35
2017-06-30	$0.21
2017-03-31	$0.26
2016-12-31	$0.13
2016-09-30	$0.23
2016-06-30	$0.16
2016-03-31	$0.30
2015-12-31	$0.06
2015-09-30	$0.19
2015-06-30	$0.17
2015-03-31	$0.15
2014-12-31	$0.14
2014-09-30	$0.15
2014-06-30	$0.19
2014-03-31	$0.41
2013-12-31	$0.18
2013-09-30	$0.21
2013-06-30	$0.19
2013-03-31	$0.16
2012-12-31	$0.16
2012-09-30	$0.11
2012-06-30	$-0.04
2012-03-31	$0.10
2011-12-31	$0.08
2011-09-30	$0.15
2011-06-30	$-0.06
2011-03-31	$0.22

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$19.522B	$22.569B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$87.081B	33.08
Zoetis (ZTS)	United States	$54.822B	19.62
Takeda Pharmaceutical (TAK)	Japan	$50.721B	10.35
Daiichi Sankyo, - (DSNKY)	Japan	$37.925B	18.89
BeOne Medicines - (ONC)	Switzerland	$37.155B	196.98
Sandoz Group AG (SDZNY)	Switzerland	$34.654B	0.00
United Therapeutics (UTHR)	United States	$20.325B	17.89
Shionogi (SGIOY)	Japan	$16.214B	14.89
Neurocrine Biosciences (NBIX)	United States	$13.697B	32.86
Summit Therapeutics (SMMT)	United States	$13.395B	0.00
IPSEN (IPSEY)	France	$13.337B	0.00
Ionis Pharmaceuticals (IONS)	United States	$13.248B	0.00
Madrigal Pharmaceuticals (MDGL)	United States	$11.311B	0.00
Orion OYJ (ORINY)	Finland	$10.204B	29.15
Eisai (ESAIY)		$8.236B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$6.967B	21.19
Grifols, S.A (GRFS)	Spain	$6.264B	0.00
Stevanato Group S.p.A (STVN)	Italy	$5.802B	32.47
Crinetics Pharmaceuticals (CRNX)	United States	$5.214B	0.00
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.547B	0.00
Corcept Therapeutics (CORT)	United States	$4.344B	46.93
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$4.269B	20.27
Indivior (INDV)	United States	$4.193B	17.11
NewAmsterdam Pharma (NAMS)	Netherlands	$3.947B	0.00
Centessa Pharmaceuticals (CNTA)	United Kingdom	$3.313B	0.00
Hypermarcas (HYPMY)	Brazil	$3.192B	21.91
Catalyst Pharmaceuticals (CPRX)	United States	$3.005B	9.59
Dyne Therapeutics (DYN)	United States	$2.582B	0.00
Ocular Therapeutix (OCUL)	United States	$2.369B	0.00
Soleno Therapeutics (SLNO)	United States	$2.350B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$2.103B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$1.959B	23.22
Ardelyx (ARDX)	United States	$1.927B	0.00
Guardian Pharmacy Services (GRDN)	United States	$1.924B	37.06
Amylyx Pharmaceuticals (AMLX)	United States	$1.782B	0.00
Oruka Therapeutics (ORKA)	United States	$1.720B	0.00
Harrow (HROW)	United States	$1.679B	103.00
Enliven Therapeutics (ELVN)	United States	$1.604B	0.00
Collegium Pharmaceutical (COLL)	United States	$1.489B	7.37
BioCryst Pharmaceuticals (BCRX)	United States	$1.422B	84.38
Relay Therapeutics (RLAY)	United States	$1.317B	0.00
Savara (SVRA)	United States	$1.314B	0.00
Evotec AG (EVO)	Germany	$1.275B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.263B	0.00
Aktis Oncology (AKTS)	United States	$1.135B	0.00
Theravance Biopharma (TBPH)	United States	$1.051B	44.13
ARS Pharmaceuticals (SPRY)	United States	$1.045B	0.00
Cronos Group (CRON)	Canada	$1.023B	0.00
Xencor (XNCR)	United States	$0.936B	0.00
Ironwood Pharmaceuticals (IRWD)	United States	$0.877B	20.73
KalVista Pharmaceuticals (KALV)	United States	$0.836B	0.00
Esperion Therapeutics (ESPR)	United States	$0.758B	0.00
Nektar Therapeutics (NKTR)	United States	$0.743B	0.00
Rigel Pharmaceuticals (RIGL)	United States	$0.688B	6.15
Bioventus (BVS)	United States	$0.675B	13.81
ProKidney (PROK)	United States	$0.656B	0.00
Altimmune (ALT)	United States	$0.561B	0.00
Lexeo Therapeutics (LXEO)	United States	$0.561B	0.00
Lyell Immunopharma (LYEL)	United States	$0.549B	0.00
Zevra Therapeutics (ZVRA)	United States	$0.511B	0.00
Organogenesis (ORGO)	United States	$0.508B	0.00
Elite Pharmaceuticals (ELTP)	United States	$0.494B	0.00
Aclaris Therapeutics (ACRS)	United States	$0.491B	0.00
Siga Technologies (SIGA)	United States	$0.482B	6.60
4D Molecular Therapeutics (FDMT)	United States	$0.462B	0.00
Nature's Sunshine Products (NATR)	United States	$0.429B	25.56
USANA Health Sciences (USNA)	United States	$0.412B	11.48
Aquestive Therapeutics (AQST)	United States	$0.397B	0.00
Cybin (HELP)	Canada	$0.385B	0.00
Akebia Therapeutics (AKBA)	United States	$0.382B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.314B	0.00
Protara Therapeutics (TARA)	United States	$0.305B	0.00
Avalo Therapeutics (AVTX)	United States	$0.301B	0.00
OmniAb (OABI)	United States	$0.298B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.294B	0.00
Relmada Therapeutics (RLMD)	United States	$0.290B	0.00
Larimar Therapeutics (LRMR)	United States	$0.286B	0.00
Fractyl Health (GUTS)	United States	$0.284B	0.00
Profound Medical (PROF)	Canada	$0.281B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.275B	0.00
Heron Therapeutics (HRTX)	United States	$0.266B	0.00
Journey Medical (DERM)	United States	$0.251B	0.00
Enlivex Therapeutics (ENLV)	Israel	$0.249B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.231B	0.00
Galectin Therapeutics (GALT)	United States	$0.228B	0.00
MediWound (MDWD)	Israel	$0.225B	0.00
Century Therapeutics (IPSC)	United States	$0.202B	0.00
AleAnna (ANNA)	United States	$0.187B	0.00
Innate Pharma SA (IPHYF)	France	$0.181B	0.00
Surrozen (SRZN)	United States	$0.171B	0.00
Minerva Neurosciences (NERV)	United States	$0.169B	0.00
Context Therapeutics (CNTX)	United States	$0.164B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.161B	0.00
VAXART, INC (VXRT)	United States	$0.159B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.156B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.153B	0.00
Prelude Therapeutics (PRLD)	United States	$0.139B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.135B	0.00
Avita Medical (RCEL)	United States	$0.126B	0.00
Incannex Healthcare (IXHL)	Australia	$0.124B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.124B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.122B	0.00
Cassava Sciences (SAVA)	United States	$0.112B	0.00
Vivani Medical (VANI)	United States	$0.107B	0.00
Pyxis Oncology (PYXS)	United States	$0.106B	0.00
Cardiol Therapeutics (CRDL)	Canada	$0.104B	0.00
Korro Bio (KRRO)	United States	$0.099B	0.00
Champions Oncology (CSBR)	United States	$0.096B	40.76
Gain Therapeutics (GANX)	United States	$0.080B	0.00
PolyPid (PYPD)	Israel	$0.076B	0.00
Assertio Holdings (ASRT)	United States	$0.075B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.069B	0.00
Dominari Holdings (DOMH)	United States	$0.068B	0.00
Metagenomi Therapeutics (MGX)	United States	$0.066B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.064B	0.00
Arch Biopartners (ACHFF)	Canada	$0.062B	0.00
Rafael Holdings (RFL)	United States	$0.062B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.061B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.060B	50.50
Lipocine (LPCN)	United States	$0.058B	0.00
ElectroCore (ECOR)	United States	$0.056B	0.00
Nutriband (NTRB)	United States	$0.055B	0.00
Lite Strategy (LITS)	United States	$0.049B	0.00
Talphera (TLPH)	United States	$0.047B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.046B	0.00
Plus Therapeutics (PSTV)	United States	$0.040B	0.00
FibroGen (FGEN)	United States	$0.039B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.039B	0.00
Wellgistics Health (WGRX)	United States	$0.036B	0.00
Mural Oncology (MURA)	Ireland	$0.035B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.034B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.032B	0.00
SCYNEXIS (SCYX)	United States	$0.032B	0.00
TherapeuticsMD (TXMD)	United States	$0.030B	0.00
Natural Alternatives (NAII)	United States	$0.027B	0.00
Klotho Neurosciences (KLTO)	United States	$0.025B	0.00
Liminatus Pharma (LIMN)	United States	$0.021B	0.00
Scienture Holdings (SCNX)	United States	$0.021B	0.00
Traws Pharma (TRAW)	United States	$0.020B	0.03
Inotiv (NOTV)	United States	$0.020B	0.00
VYNE Therapeutics (VYNE)	United States	$0.019B	0.00
Cosmos Health (COSM)	United States	$0.019B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.019B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.018B	0.00
Vivos Therapeutics (VVOS)	United States	$0.017B	0.00
Vyome Holdings (HIND)	United States	$0.016B	0.00
Tempest Therapeutics (TPST)	United States	$0.015B	0.00
Mannatech (MTEX)	United States	$0.014B	0.00
BioLineRx (BLRX)	Israel	$0.013B	0.00
CASI Pharmaceuticals (CASI)	China	$0.012B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.012B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.011B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.010B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.010B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.010B	0.00
BioVie (BIVI)	United States	$0.009B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.009B	0.00
Nuvilex (PMCB)	United States	$0.009B	0.00
Ainos (AIMD)	United States	$0.009B	0.00
Mangoceuticals (MGRX)	United States	$0.009B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.009B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.008B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.008B	0.00
Biomerica (BMRA)	United States	$0.008B	0.00
Heatwurx (PCSA)	United States	$0.007B	0.00
Redhill Biopharma (RDHL)	Israel	$0.007B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.007B	0.00
Indaptus Therapeutics (INDP)	United States	$0.006B	0.00
Xenetic Biosciences (XBIO)	United States	$0.006B	0.00
Aptorum Group (APM)	United Kingdom	$0.006B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.006B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.005B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
Clearmind Medicine (CMND)	Canada	$0.004B	0.00
Lyra Therapeutics (LYRA)	United States	$0.004B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.004B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.004B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.003B	0.00
Jaguar Animal Health (JAGX)	United States	$0.003B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.002B	0.00
CDT Equity (CDT)	United States	$0.002B	0.00
PainReform (PRFX)	Israel	$0.002B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.001B	0.00
Aditxt (ADTX)	United States	$0.001B	0.00
SciSparc (SPRC)	Israel	$0.001B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00